These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 28404521)

  • 1. Diabetic complications in the cornea.
    Ljubimov AV
    Vision Res; 2017 Oct; 139():138-152. PubMed ID: 28404521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New therapeutic approaches in the treatment of diabetic keratopathy: a review.
    Abdelkader H; Patel DV; McGhee CNj; Alany RG
    Clin Exp Ophthalmol; 2011 Apr; 39(3):259-70. PubMed ID: 20973888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discoveries in research on diabetic keratopathy.
    Cisarik-Fredenburg P
    Optometry; 2001 Nov; 72(11):691-704. PubMed ID: 12363257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular surface abnormalities related to type 2 diabetes are reversed by the opioid antagonist naltrexone.
    Zagon IS; Sassani JW; Immonen JA; McLaughlin PJ
    Clin Exp Ophthalmol; 2014 Mar; 42(2):159-68. PubMed ID: 23777539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)-OGF receptor (OGFr) axis with naltrexone: a review.
    McLaughlin PJ; Sassani JW; Klocek MS; Zagon IS
    Brain Res Bull; 2010 Feb; 81(2-3):236-47. PubMed ID: 19683562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical application of naltrexone facilitates reepithelialization of the cornea in diabetic rabbits.
    Zagon IS; Sassani JW; Carroll MA; McLaughlin PJ
    Brain Res Bull; 2010 Feb; 81(2-3):248-55. PubMed ID: 19853024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The cornea: stasis and dynamics].
    Nishida T
    Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):179-212; discussion 213. PubMed ID: 18411711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldose reductase, ocular diabetic complications and the development of topical Kinostat(®).
    Kador PF; Wyman M; Oates PJ
    Prog Retin Eye Res; 2016 Sep; 54():1-29. PubMed ID: 27102270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of abnormal corneal epithelial cell morphologic characteristics and reduced corneal sensitivity in diabetic patients by aldose reductase inhibitor, CT-112.
    Hosotani H; Ohashi Y; Yamada M; Tsubota K
    Am J Ophthalmol; 1995 Mar; 119(3):288-94. PubMed ID: 7872388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldose reductase inhibitor (CT-112) eyedrops for diabetic corneal epitheliopathy.
    Ohashi Y; Matsuda M; Hosotani H; Tano Y; Ishimoto I; Fukuda M; Manabe R
    Am J Ophthalmol; 1988 Mar; 105(3):233-8. PubMed ID: 3125744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naltrexone accelerates healing without compromise of adhesion complexes in normal and diabetic corneal epithelium.
    Zagon IS; Sassani JW; Myers RL; McLaughlin PJ
    Brain Res Bull; 2007 Apr; 72(1):18-24. PubMed ID: 17303503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular surface complications in diabetes: The interrelationship between insulin and enkephalin.
    Purushothaman I; Zagon IS; Sassani JW; McLaughlin PJ
    Biochem Pharmacol; 2021 Oct; 192():114712. PubMed ID: 34324868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of corneal sensation and tear dynamics in diabetic patients by oral aldose reductase inhibitor, ONO-2235: a preliminary study.
    Fujishima H; Shimazaki J; Yagi Y; Tsubota K
    Cornea; 1996 Jul; 15(4):368-75. PubMed ID: 8776562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of sensory neuropathy and inflammation on epithelial wound healing in diabetic corneas.
    Yu FX; Lee PSY; Yang L; Gao N; Zhang Y; Ljubimov AV; Yang E; Zhou Q; Xie L
    Prog Retin Eye Res; 2022 Jul; 89():101039. PubMed ID: 34991965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in corneal wound healing.
    Ljubimov AV; Saghizadeh M
    Prog Retin Eye Res; 2015 Nov; 49():17-45. PubMed ID: 26197361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental modeling of cornea wound healing in diabetes: clinical applications and beyond.
    Bu Y; Shih KC; Kwok SS; Chan YK; Lo AC; Chan TCY; Jhanji V; Tong L
    BMJ Open Diabetes Res Care; 2019; 7(1):e000779. PubMed ID: 31803484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized Controlled Trial of Topical Insulin for Healing Corneal Epithelial Defects Induced During Vitreoretinal Surgery in Diabetics.
    Fai S; Ahem A; Mustapha M; Mohd Noh UK; Bastion MC
    Asia Pac J Ophthalmol (Phila); 2017; 6(5):418-424. PubMed ID: 28828764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corneal Epithelial Changes in Diabetic Patients: A Review.
    Ladea L; Zemba M; Calancea MI; Călțaru MV; Dragosloveanu CDM; Coroleucă R; Catrina EL; Brezean I; Dinu V
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic investigations of diabetic ocular surface diseases.
    Zhou Q; Yang L; Wang Q; Li Y; Wei C; Xie L
    Front Endocrinol (Lausanne); 2022; 13():1079541. PubMed ID: 36589805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal delivery of nanomicelle curcumin promotes corneal epithelial wound healing in streptozotocin-induced diabetic mice.
    Guo C; Li M; Qi X; Lin G; Cui F; Li F; Wu X
    Sci Rep; 2016 Jul; 6():29753. PubMed ID: 27405815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.